EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieStudienprotokollOpen Access

Association between NT-proBNP and ivabradine in patients after noncardiac surgery: a per-protocol analysis of the PREVENT-MINS study

Jacek Gorka, Zbigniew Putowski, Anna Wludarczyk, Michal Jedrusiak, Szymon Bialka, Piotr Palaczynski, Michał Borys, Paweł Kutnik, Tomasz Czarnik, Anna Szczepanska, Stanisław Wawrzyniak, Marcin Mozanski und 11 weitere

Anaesthesiology Intensive Therapy · 2025

DOI: 10.5114/ait/216162 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Anaesthesiology Intensive Therapy, 2025. Verfasst von Jacek Gorka und 22 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Intensive Care and Perioperative Medicine, Jagiellonian University Medical College, Krakow, Poland. Hauptthemen laut MEDLINE: Ivabradine, Natriuretic Peptide, Brain, Peptide Fragments, Postoperative Complications. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The PREVENT-MINS trial investigated whether perioperative heart rate reduction with ivabradine could prevent myocardial injury after noncardiac surgery (MINS). Although ivabradine modestly reduced heart rate, it did not reduce the incidence of MINS in the intention-to-treat analysis. This per-protocol analysis of the PREVENT-MINS trial, with a post-hoc biomarker substudy, evaluated whether perioperative iva­bradine modifies postoperative N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations, a marker of perioperative cardiovascular risk.

Methods

This analysis included 2008 participants who received ≥ 1 dose of study drug, underwent surgery, and had NT-proBNP and troponin measured (ivabradine: n = 1,001; placebo: n = 1,007). Postoperative NT-proBNP levels and changes from baseline (ΔNT-proBNP) were compared by treatment allocation. Clinical outcomes and safety endpoints from the parent trial were evaluated. Analysis of covariance (ANCOVA) assessed ivabradine’s effect on postoperative NT-proBNP after adjustment for baseline values and clinical covariates.

Results

MINS occurred in 17.7% of ivabradine-treated vs. 15.7% of placebo patients (RR 1.13; 95% CI: 0.93–1.37; P = 0.23). Median postoperative NT-proBNP was higher with ivabradine than with placebo (418.0 vs. 333.5 pg mL–1; P < 0.001), as were ΔNT-proBNP values (215.1 vs. 154.0 pg mL–1; P < 0.001). After adjustment for baseline and relevant clinical covariates, ivabradine was independently associated with an approximately 82% increase in postoperative NT-proBNP (Δlog = 0.59 ± 0.19; 95% CI: 26–164).

Conclusions

Ivabradine did not reduce the incidence of MINS and was associated with greater postoperative NT-proBNP release. Perioperative heart rate reduction with ivabradine may elevate markers of cardiac stress without measurable clinical benefit.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IvabradineNatriuretic Peptide, BrainPeptide FragmentsPostoperative ComplicationsCardiovascular AgentsHumansFemaleMaleMiddle AgedAgedBiomarkersHeart RateDouble-Blind Method

Stichwörter der Autor:innen

NT-proBNPivabradinemyocardial injurynoncardiac surgeryper-protocol analysisrandomized controlled trial

Substanzen

IvabradineNatriuretic Peptide, Brainpro-brain natriuretic peptide (1-76)Peptide FragmentsBiomarkersCardiovascular Agents

Autor:innen und Institutionen

  • Centre for Intensive Care and Perioperative Medicine, Jagiellonian University Medical College, Krakow, Poland.
  • Department of Anesthesiology and Intensive Care, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland.
  • Faculty of Medicine, Institute of Medical Sciences, The John Paul II Catholic University of Lublin, Poland.
  • Department of Anesthesiology and Intensive Care, Institute of Medical Sciences, University of Opole, Poland.
  • Department of Anesthesiology and Intensive Care, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.
  • Doctoral School, Medical University of Silesia, Katowice, Poland.

Zitieren

APA

Gorka, J., Putowski, Z., Wludarczyk, A., Jedrusiak, M., Bialka, S., Palaczynski, P., Borys, M., Kutnik, P., Czarnik, T., Szczepanska, A., Wawrzyniak, S., Mozanski, M., Keska, M., Kotfis, K., Trzebicki, J., Aszkielaniec, J., Solek-Pastuszka, J., Grudzien, P., Mudyna, W., …, & Szczeklik, W. (2025). Association between NT-proBNP and ivabradine in patients after noncardiac surgery: a per-protocol analysis of the PREVENT-MINS study. Anaesthesiology Intensive Therapy. https://doi.org/10.5114/ait/216162

Vancouver

Gorka J, Putowski Z, Wludarczyk A, Jedrusiak M, Bialka S, Palaczynski P, et al. Association between NT-proBNP and ivabradine in patients after noncardiac surgery: a per-protocol analysis of the PREVENT-MINS study. Anaesthesiology Intensive Therapy. 2025. doi:10.5114/ait/216162

BibTeX
@article{Gorka2025,
  author = {Gorka, Jacek and Putowski, Zbigniew and Wludarczyk, Anna and Jedrusiak, Michal and Bialka, Szymon and Palaczynski, Piotr and Borys, Michał and Kutnik, Paweł and Czarnik, Tomasz and Szczepanska, Anna and Wawrzyniak, Stanisław and Mozanski, Marcin and Keska, Milena and Kotfis, Katarzyna and Trzebicki, Janusz and Aszkielaniec, Jan and Solek-Pastuszka, Joanna and Grudzien, Pawel and Mudyna, Wojciech and Kreczko, Mateusz and Zhao, Zhiguo and Devereaux, P J and Szczeklik, Wojciech},
  title = {Association between NT-proBNP and ivabradine in patients after noncardiac surgery: a per-protocol analysis of the PREVENT-MINS study},
  journal = {Anaesthesiology Intensive Therapy},
  year = {2025},
  doi = {10.5114/ait/216162}
}
Kostenlos starten →